204 related articles for article (PubMed ID: 29381352)
1. Design and Mechanism of (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic Acid, a Highly Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Addiction.
Juncosa JI; Takaya K; Le HV; Moschitto MJ; Weerawarna PM; Mascarenhas R; Liu D; Dewey SL; Silverman RB
J Am Chem Soc; 2018 Feb; 140(6):2151-2164. PubMed ID: 29381352
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Inactivation of GABA Aminotransferase by (E)- and (Z)-(1S,3S)-3-Amino-4-fluoromethylenyl-1-cyclopentanoic Acid.
Lee H; Le HV; Wu R; Doud E; Sanishvili R; Kellie JF; Compton PD; Pachaiyappan B; Liu D; Kelleher NL; Silverman RB
ACS Chem Biol; 2015 Sep; 10(9):2087-98. PubMed ID: 26110556
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of inactivation of γ-aminobutyric acid aminotransferase by (1S,3S)-3-amino-4-difluoromethylene-1-cyclopentanoic acid (CPP-115).
Lee H; Doud EH; Wu R; Sanishvili R; Juncosa JI; Liu D; Kelleher NL; Silverman RB
J Am Chem Soc; 2015 Feb; 137(7):2628-40. PubMed ID: 25616005
[TBL] [Abstract][Full Text] [Related]
4. (1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent γ-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addiction.
Pan Y; Gerasimov MR; Kvist T; Wellendorph P; Madsen KK; Pera E; Lee H; Schousboe A; Chebib M; Bräuner-Osborne H; Craft CM; Brodie JD; Schiffer WK; Dewey SL; Miller SR; Silverman RB
J Med Chem; 2012 Jan; 55(1):357-66. PubMed ID: 22128851
[TBL] [Abstract][Full Text] [Related]
5. The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms.
Silverman RB
J Med Chem; 2012 Jan; 55(2):567-75. PubMed ID: 22168767
[No Abstract] [Full Text] [Related]
6. Selective Targeting by a Mechanism-Based Inactivator against Pyridoxal 5'-Phosphate-Dependent Enzymes: Mechanisms of Inactivation and Alternative Turnover.
Mascarenhas R; Le HV; Clevenger KD; Lehrer HJ; Ringe D; Kelleher NL; Silverman RB; Liu D
Biochemistry; 2017 Sep; 56(37):4951-4961. PubMed ID: 28816437
[TBL] [Abstract][Full Text] [Related]
7. Design and mechanism of tetrahydrothiophene-based γ-aminobutyric acid aminotransferase inactivators.
Le HV; Hawker DD; Wu R; Doud E; Widom J; Sanishvili R; Liu D; Kelleher NL; Silverman RB
J Am Chem Soc; 2015 Apr; 137(13):4525-33. PubMed ID: 25781189
[TBL] [Abstract][Full Text] [Related]
8. Molecular dynamics simulations of apo, holo, and inactivator bound GABA-at reveal the role of active site residues in PLP dependent enzymes.
Gökcan H; Monard G; Sungur Konuklar FA
Proteins; 2016 Jul; 84(7):875-91. PubMed ID: 26800298
[TBL] [Abstract][Full Text] [Related]
9. Structural modifications of (1S,3S)-3-amino-4-difluoromethylenecyclopentanecarboxylic acid, a potent irreversible inhibitor of GABA aminotransferase.
Yuan H; Silverman RB
Bioorg Med Chem Lett; 2007 Mar; 17(6):1651-4. PubMed ID: 17267220
[TBL] [Abstract][Full Text] [Related]
10. Design and Mechanism of GABA Aminotransferase Inactivators. Treatments for Epilepsies and Addictions.
Silverman RB
Chem Rev; 2018 Apr; 118(7):4037-4070. PubMed ID: 29569907
[TBL] [Abstract][Full Text] [Related]
11. Theoretical and Mechanistic Validation of Global Kinetic Parameters of the Inactivation of GABA Aminotransferase by OV329 and CPP-115.
Weerawarna PM; Moschitto MJ; Silverman RB
ACS Chem Biol; 2021 Apr; 16(4):615-630. PubMed ID: 33735567
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic crystallography. Mechanism of inactivation of gamma-aminobutyric acid aminotransferase by (1R,3S,4S)-3-amino-4-fluorocyclopentane-1-carboxylic acid as elucidated by crystallography.
Storici P; Qiu J; Schirmer T; Silverman RB
Biochemistry; 2004 Nov; 43(44):14057-63. PubMed ID: 15518554
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of ( S)-3-Amino-4-(difluoromethylenyl)-cyclopent-1-ene-1-carboxylic Acid (OV329), a Potent Inactivator of γ-Aminobutyric Acid Aminotransferase.
Moschitto MJ; Silverman RB
Org Lett; 2018 Aug; 20(15):4589-4592. PubMed ID: 30009604
[TBL] [Abstract][Full Text] [Related]
14. Design of a conformationally restricted analogue of the antiepilepsy drug Vigabatrin that directs its mechanism of inactivation of gamma-aminobutyric acid aminotransferase.
Choi S; Storici P; Schirmer T; Silverman RB
J Am Chem Soc; 2002 Feb; 124(8):1620-4. PubMed ID: 11853435
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase.
Hawker DD; Silverman RB
Bioorg Med Chem; 2012 Oct; 20(19):5763-73. PubMed ID: 22944334
[TBL] [Abstract][Full Text] [Related]
16. (+/-)-(1S,2R,5S)-5-Amino-2-fluorocyclohex-3-enecarboxylic acid. A potent GABA aminotransferase inactivator that irreversibly inhibits via an elimination-aromatization pathway.
Wang Z; Yuan H; Nikolic D; Van Breemen RB; Silverman RB
Biochemistry; 2006 Dec; 45(48):14513-22. PubMed ID: 17128990
[TBL] [Abstract][Full Text] [Related]
17. Inactivation and inhibition of gamma-aminobutyric acid aminotransferase by conformationally restricted vigabatrin analogues.
Choi S; Silverman RB
J Med Chem; 2002 Sep; 45(20):4531-9. PubMed ID: 12238932
[TBL] [Abstract][Full Text] [Related]
18. Rational Design, Synthesis, and Mechanism of (3
Zhu W; Butrin A; Melani RD; Doubleday PF; Ferreira GM; Tavares MT; Habeeb Mohammad TS; Beaupre BA; Kelleher NL; Moran GR; Liu D; Silverman RB
J Am Chem Soc; 2022 Mar; 144(12):5629-5642. PubMed ID: 35293728
[TBL] [Abstract][Full Text] [Related]
19. A novel strategy for the treatment of cocaine addiction.
Dewey SL; Morgan AE; Ashby CR; Horan B; Kushner SA; Logan J; Volkow ND; Fowler JS; Gardner EL; Brodie JD
Synapse; 1998 Oct; 30(2):119-29. PubMed ID: 9723781
[TBL] [Abstract][Full Text] [Related]
20. Structures of gamma-aminobutyric acid (GABA) aminotransferase, a pyridoxal 5'-phosphate, and [2Fe-2S] cluster-containing enzyme, complexed with gamma-ethynyl-GABA and with the antiepilepsy drug vigabatrin.
Storici P; De Biase D; Bossa F; Bruno S; Mozzarelli A; Peneff C; Silverman RB; Schirmer T
J Biol Chem; 2004 Jan; 279(1):363-73. PubMed ID: 14534310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
